CIDRAP newsletters options
COVID-19 patients had persistent signs of heart and lung involvement, inflammation, and clotting.
California and Washington state report their first cases, as CDC experts advise on what doctors should be alert for.
The agency also alerts clinicians about COVID-19 rebound after Paxlovid.
A study from Israel published today in BMJ shows that the effectiveness of a fourth dose of Pfizer-BioNTech's mRNA COVID vaccine waned faster than a third dose in adults ages 60 and older.
Flu levels are up sharply in some Australian states, putting pressure on healthcare systems that are also coping with ongoing COVID-19 activity and prompting more efforts to get more people vaccinated against flu.
Compared with Omicron, MIS-C rate was 14 times higher amid Alpha and 13 times higher during Delta.
The CDC says many patients have a distinctive monkeypox rash around their genitals, and UK officials report 36 new infections.
A plant closing could affect 5 essential generic drugs for which Teva had an over 15% market share.
FDA advisers will meet in a few weeks to discuss emergency use of 3 doses.
While COVID-19–related thyroid inflammation usually resolves shortly after the acute illness, about half of participants in a study presented today at the 24th European Congress of Endocrinology still had thyroid abnormalities a year later. The congress is being held May 21 to 24 in Milan, Italy.
The World Health Organization (WHO) last week published its strategic priorities for tackling antimicrobial resistance (AMR).
The document lays out four strategic priority areas that incorporate what the WHO says are the essential components of the AMR response at global, regional, and country levels. It also lists the key achievements and the next steps that need to be taken in those four areas.
At least 8 European countries and Canada, the US, and Australia have tallied cases.
Only 16% of people in low-income countries have received a single COVID vaccine dose.
A large study shows a 12.8% long COVID decline after the first dose and an 8.8% drop after the second.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
More adults died of COVID-19 in Massachusetts in the first 8 weeks of the SARS-CoV-2 Omicron variant surge than in the entire 23-week Delta period, suggests a modeling study published today in JAMA.
A study by Centers for Disease Control and Prevention researchers found that, despite changes in infection control practices, antibiotic use, and healthcare delivery during the first year of the COVID-19 pandemic, Clostridioides difficile infection rates did not change. The findings were published yesterday in Infection Control & Hospital Epidemiology.
As cases climb in several nations, an expert notes, "We are much more susceptible to poxviruses."
The recommendation passed with 11 yes votes, 1 no vote, and 1 abstention.
Allergic conditions were not elevated in preschoolers.
